About CancerIQ
CancerIQ is a private company based in Chicago, Illinois. It has reported $19,904,993 raised in three offerings on Form D since April 2020. Its chief executive is Olufeyikemi Ayodele.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 1, 2023 | Nov 13, 2023amended May 26, 2026 | $4,284,000of $6.0M target | 9 | $476K | Debt, Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Mar 2, 2022 | Apr 8, 2022 | $14,000,293fully sold | 6 | $2.3M | EquityRule 506(b) | Form D ↗ |
| Feb 27, 2020 | Apr 23, 2020 | $1,620,700of $2.5M target | 5 | $324K | Equity, Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, three offerings | $19,904,993 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on CancerIQ's Form D filed May 26, 2026.
Earlier filings also listed Andrea Metkus (director, last listed Apr 2022), Paul Burton (executive officer, last listed Apr 2020), Olufunmilayo Olapade (director, last listed Apr 2020), Jordan Dolin (director, last listed Apr 2020), Evan Wood (director, last listed Apr 2020) and Christopher Bun (executive officer, last listed Apr 2020).